Successful hyaluronic acid filler injection in a chronic myeloid leukemia patient taking imatinib mesylate.
Abstract
Dermal fillers are highly favored around the globe as minimally invasive or nonsurgical procedures. Imatinib mesylate is the first-line treatment for patients diagnosed with chronic myeloid leukemia. However, some studies describe that imatinib mesylate may increase the tendency of skin fragility which can lead to easy bruising and hyperpigmentation after invasive skin procedures. Yet, to our knowledge, no studies have described any successful dermal filler injection performed on patients who are under imatinib mesylate treatment. Hence, we present a case successfully treated with hyaluronic acid filler injection on a patient under imatinib mesylate treatment. We carefully propose that hyaluronic acid filler can be an effective means of rejuvenation and cosmetic enhancement for those under imatinib mesylate treatment.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | hyaluronic acid filler
|
필러 주입술 | dict | 3 | |
| 재료 | hyaluronic acid
|
히알루론산 | dict | 3 | |
| 시술 | dermal filler
|
필러 주입술 | dict | 1 | |
| 합병증 | hyperpigmentation
|
색소침착 | dict | 1 |
MeSH Terms
Adult; Dermal Fillers; Esthetics; Female; Humans; Hyaluronic Acid; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nose
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- Choroidal ischemia after self-injection of hyaluronic acid filler.
- Intra-articular therapies for synovial joint dysfunction: a comprehensive integrative review.
- Clinical safety of a low-modification hyaluronic acid filler (MoD 2%) for facial rejuvenation.
- Red and near-infrared photobiomodulation for burn, hypertrophic, and post-surgical scars: a scoping review of clinical trials.